Different inflammatory signatures in Alzheimer’s disease and frontotemporal dementia cerebrospinal fluid
Manuscript Number:
20-1565R2
Author(s):
Daniel Alcolea, Gustaf Boström, RoseMarie Brundin, Eva Freyhult, Vilmantas Giedraitis, Martin Ingelsson, Lena Kilander, Kim Kultima, Alberto Lleó, Malin Löwenmark, Markus Otto, Hayrettin Tumani, Johan Virhammar, Christine A.F. von Arnim
Disclosures
Daniel Alcolea
Consulting Fees:
I participated in advisory boards from Fujirebio-Europe and Roche Diagnostics
Lecture Fees:
I have received speaker honoraria from Fujirebio-Europe, Roche Diagnostics, Nutricia and from Krka Farmacéutica S.L.
Patents/Royalties
I declare a filed patent application (WO2019175379 A1 Markers of synaptopathy in neurodegenerative disease).
Gustaf Boström
Nothing to Disclose
RoseMarie Brundin
Nothing to Disclose
Eva Freyhult
Nothing to Disclose
Vilmantas Giedraitis
Nothing to Disclose
Martin Ingelsson
Consulting Fees:
I am advisory board member for BioArctic. I receive about 20 000-30 000 SEK/year (2-3 000 Euro/year).
Lena Kilander
Nothing to Disclose
Kim Kultima
Nothing to Disclose
Alberto Lleó
Nothing to Disclose
Malin Löwenmark
Nothing to Disclose
Markus Otto
Consulting Fees:
Member of advisory board for Axon, Biogen, Alector
Hayrettin Tumani
Lecture Fees:
Lectures on Multiple sclerosis diagnostics and therapy not related to the content of this paper.
Grants
Agency:
Genzyme
Dates:
2018-2020
Johan Virhammar
Nothing to Disclose
Christine A.F. von Arnim
Consulting Fees:
CAFvA received honoraria from serving on the scientific advisory board of Biogen, Roche, and Dr. Willmar Schwabe GmbH &Co. KG
Lecture Fees:
Funding for travel and speaker honoraria from Biogen, Roche diagnostics AG and Dr. Willmar Schwabe GmbH &Co. KG.